|
|
|
MIRA
INFORM REPORT
|
Report No. : |
494152 |
|
Report Date : |
28.02.2018 |
IDENTIFICATION DETAILS
|
Name : |
GROUP PHARMACEUTICALS LIMITED (w.e.f 21.04.1993) |
|
|
|
|
Formerly Known As
: |
GROUP PHARMACEUTICALS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
W-46, (B) MIDC, Tarapur Industrial Area, Thane – 401506, |
|
Tel. No.: |
91-22-28722695 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
24.07.1980 |
|
|
|
|
Com. Reg. No.: |
11-022889 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 25.368 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239MH1980PLC022889 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
Not Divulged |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMG08042G MUMG08531F |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
27AAACG8723H1ZK |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACG8723H |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in the activities pertaining to manufacturing and marketing a wide range of pharmaceutical formulations with special focus in the areas of Dental and Oral care products. (Registered activity) |
|
|
|
|
No. of Employees
: |
Information declined by the management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Maximum Credit Limit : |
USD 750000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject was incorporated in the year 1980 and it is engaged in business of manufacturing, exporting, selling, importing and dealing in pharmaceutical products. It is an old and established company having fine track record. For the financial year 2017, the company has reported marginal decline in its revenue as compared to its previous year but has registered with good profit margin during the year. Rating reflects company’s sound financial profile marked by favourable profitability, good net worth base along with strong debt protection metrics. Rating continue to derive strength from its long and established track record of its business operation backed by established market position and extensive experience of the promoters in the pharmaceutical industry. However, these rating strengths gets partially offset by intense competition in the international market, and growing regulatory scrutiny in emerging market, along with growing competition, substantial investment in infrastructure and R&D which impact in profitability pressure amongst the major players. Payments seems to be regular. In view of aforesaid, the company can be considered for business dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low
Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High
Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
Not Available |
|
Rating |
Not Available |
|
Rating Explanation |
Not Available |
|
Date |
Not Available |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction)
LISTING STATUS
Subject’s name is
not listed as a Sick Unit in the publicly available BIFR (Board for Industrial
& Financial Reconstruction) list as of 28.02.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DENIED
MANAGEMENT NON-COOPERATIVE: TEL. No.: 91-22-28722695 / 91-80-23376766
LOCATIONS
|
Registered Office/ Factory 1 : |
W-46 (B), MIDC, Tarapur Industrial Area, Boisar (West), District Thane
– 401506, |
|
Tel. No.: |
91-22-28722695 |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory 2 : |
Group Malur, Plant II, Plot No 41, Nasigere Village, Kasaba Hobli,
Industrial Area, Malur Kolar, Malur Kolar - 563130, Karnataka, India |
|
Tel No.: |
91-8151-234237/ 235220 |
|
Fax No.: |
91-8151-235084 |
|
Email : |
|
|
|
|
|
Corporate/ Head Office : |
|
|
Tel. No.: |
91-22-28722695 |
|
Fax No.: |
91-22-28724883 |
|
E-Mail : |
|
|
|
|
|
Sales / Marketing Office : |
521/A, 2nd Block, 2nd Main, 2nd Stage, Rajajinagar, |
|
Tel. No.: |
91-80-23377962/ 23376766 |
|
Fax No.: |
91-80-23372277 |
|
E-Mail : |
|
|
|
|
|
Central Warehouse : |
Vrindavan Complex, Khalrapada Boisar, District Thane – 401506, Maharashtra, India |
|
Tel. No.: |
91-2525-254067 |
DIRECTORS
As on 31.03.2017
|
Name : |
Mr. Sunil Ravindranath Attavar |
||||||||||||||||||||
|
Designation : |
Managing Director |
||||||||||||||||||||
|
Address : |
Plot No.409, 9th Main, Kallyna Nagar, 1st Block, HRBR Layout,
Banaswadi, |
||||||||||||||||||||
|
Date of Birth/Age : |
28.09.1966 |
||||||||||||||||||||
|
Qualification : |
Graduate in Biochemistry |
||||||||||||||||||||
|
Date of Appointment : |
15.08.2016 |
||||||||||||||||||||
|
PAN No.: |
ABRPA8487F |
||||||||||||||||||||
|
DIN No.: |
00091347 |
||||||||||||||||||||
|
Other Directorship:
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
Name : |
Mr. Ann Sunil Attavar |
||||||||||||||||||||
|
Designation : |
Whole Time Director |
||||||||||||||||||||
|
Address : |
Plot No.409, 9th Main Kalyana Nagar, 1st Block,
HRBR Layout Banaswadi, |
||||||||||||||||||||
|
Date of Birth/Age : |
10.08.1965 |
||||||||||||||||||||
|
Qualification : |
Graduate in Biochemistry, P.G. Diploma in analytical and Industrial Chemistry |
||||||||||||||||||||
|
Date of Appointment : |
15.09.2008 |
||||||||||||||||||||
|
PAN No.: |
AACPA8433F |
||||||||||||||||||||
|
DIN No.: |
00091390 |
||||||||||||||||||||
|
Other Directorship:
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
Name : |
Mr. Gopal Jagdeshwar Singh |
||||||||||||||||||||
|
Designation : |
Whole Time Director |
||||||||||||||||||||
|
Address : |
Mama Talab, Diprapara, Bilaspur – 495003, |
||||||||||||||||||||
|
Date of Birth/Age : |
17.01.1950 |
||||||||||||||||||||
|
Qualification : |
Post graduate |
||||||||||||||||||||
|
Date of Appointment : |
06.12.1982 |
||||||||||||||||||||
|
PAN No.: |
ANOPS4173M |
||||||||||||||||||||
|
DIN No.: |
00091420 |
||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
Name : |
Mr. Ranganathan Raghunathan Naranamangalam |
||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||
|
Address : |
A-7, Ground Floor, Parsn Nagar, 36 V G P Salia, Saidapet (West), Chennai- 600015, Tamilnadu, India |
||||||||||||||||||||
|
Date of Birth/Age : |
10.05.1938 |
||||||||||||||||||||
|
Qualification : |
Post graduate |
||||||||||||||||||||
|
Date of Appointment : |
24.06.2005 |
||||||||||||||||||||
|
PAN No.: |
ACRPN1329C |
||||||||||||||||||||
|
DIN No.: |
00156574 |
||||||||||||||||||||
|
Other Directorship:
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
Name : |
Mr. Raghavendra Narayana Rao |
||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||
|
Address : |
506-A, Saraswati Aparttments, |
||||||||||||||||||||
|
Date of Birth/Age : |
16.04.1950 |
||||||||||||||||||||
|
Qualification : |
Post graduate |
||||||||||||||||||||
|
Date of Appointment : |
26.09.2006 |
||||||||||||||||||||
|
PAN No.: |
AAAPR9070P |
||||||||||||||||||||
|
DIN No.: |
01326471 |
||||||||||||||||||||
|
Other Directorship:
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
Name : |
Mr. Sundaram Rajan |
||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||
|
Address : |
B-5, Surya Nest, #57, 15th Cross, Malleswaram,
Bangalore - 560003, |
||||||||||||||||||||
|
Date of Birth/Age : |
24.07.1942 |
||||||||||||||||||||
|
Qualification : |
Post graduate |
||||||||||||||||||||
|
Date of Appointment : |
08.03.2000 |
||||||||||||||||||||
|
PAN No.: |
ABMPR9377E |
||||||||||||||||||||
|
DIN No.: |
02139522 |
||||||||||||||||||||
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 31.03.2017
SHAREHOLDERS DETAILS FILE ATTACHED
Equity Share Break up (Percentage of Total Equity)
As on 29.09.2017
|
Category |
Percentage |
|
Promoter – (Individual/ Hindu Undivided
Family – Indian) |
58.24 |
|
Public – (Individual/ Hindu
Undivided Family – Indian |
41.76 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in the activities pertaining to manufacturing and marketing a wide range of pharmaceutical formulations with special focus in the areas of Dental and Oral care products. (Registered activity) |
||||||
|
|
|
||||||
|
Products : |
|
||||||
|
|
|
||||||
|
Brand Names : |
Not Divulged |
||||||
|
|
|
||||||
|
Agencies Held : |
Not Divulged |
||||||
|
|
|
||||||
|
Exports : |
Not Divulged |
||||||
|
|
|
||||||
|
Imports : |
Not Divulged |
||||||
|
|
|
||||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Information declined by the management |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
|
Auditors : |
|
|
Name : |
G K GADGIL and Company Chartered Accountants |
|
Address : |
B 29 Sai Chambers, 1st Floor, Sector 11, Opposite IDBI Bank, CBD Belapur, Navi Mumbai – 400614, Maharashtra, India |
|
PAN N Income-tax PAN of auditor or auditor's firm : |
AAIFG2970K |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Associates/Subsidiaries : |
Not Available |
CAPITAL STRUCTURE
As on 31.03.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
5000000 |
Equity Shares |
INR 10/- each |
INR 50.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
2536800 |
Equity Shares |
INR 10/- each |
INR 25.368 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES
OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
25.368 |
25.368 |
25.368 |
|
(b) Reserves & Surplus |
238.308 |
215.216 |
205.969 |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
263.676 |
240.584 |
231.337 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
25.372 |
|
(b) Deferred tax liabilities
(Net) |
0.579 |
1.436 |
2.151 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term provisions |
0.000 |
0.000 |
0.000 |
|
Total
Non-current Liabilities (3) |
0.579 |
1.436 |
27.523 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
101.547 |
64.733 |
74.084 |
|
(b) Trade payables |
44.008 |
62.660 |
91.979 |
|
(c) Other current liabilities |
37.675 |
38.012 |
34.861 |
|
(d) Short-term provisions |
0.000 |
0.000 |
0.000 |
|
Total
Current Liabilities (4) |
183.230 |
165.405 |
200.924 |
|
|
|
|
|
|
TOTAL |
447.485 |
407.425 |
459.784 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
148.305 |
166.578 |
182.476 |
|
(ii) Intangible Assets |
2.324 |
3.208 |
2.695 |
|
(iii) Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv) Intangible assets under
development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
5.081 |
4.755 |
4.855 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total
Non-Current Assets |
155.710 |
174.541 |
190.026 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
120.532 |
97.615 |
141.653 |
|
(c) Trade receivables |
136.412 |
98.881 |
100.849 |
|
(d) Cash and cash equivalents |
11.106 |
14.955 |
13.569 |
|
(e) Short-term loans and
advances |
22.568 |
20.479 |
12.935 |
|
(f) Other current assets |
1.157 |
0.954 |
0.752 |
|
Total
Current Assets |
291.775 |
232.884 |
269.758 |
|
|
|
|
|
|
TOTAL |
447.485 |
407.425 |
459.784 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Income |
948.282 |
974.972 |
912.760 |
|
|
Other Income |
14.516 |
8.372 |
9.482 |
|
|
TOTAL
|
962.798 |
983.344 |
922.242 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials Consumed |
412.823 |
443.594 |
443.025 |
|
|
Purchases of Stock-in-Trade |
126.813 |
118.732 |
115.146 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
(6.933) |
11.709 |
(10.076) |
|
|
Employees benefits expense |
207.527 |
199.162 |
169.300 |
|
|
Other expenses |
153.780 |
148.102 |
121.121 |
|
|
TOTAL |
894.010 |
921.299 |
838.516 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
68.788 |
62.045 |
83.726 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
10.091 |
17.299 |
15.809 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
58.697 |
44.746 |
67.917 |
|
|
|
|
|
|
|
Less/
Add |
DEPRECIATION/
AMORTISATION |
24.461 |
26.537 |
27.859 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
34.236 |
18.209 |
40.058 |
|
|
|
|
|
|
|
Less |
TAX |
11.144 |
6.677 |
14.508 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
23.092 |
11.532 |
25.550 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (INR) |
9.10 |
4.55 |
10.07 |
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
Net cash flows from (used in) operations |
(24.215) |
56.365 |
31.556 |
|
Net cash flows from (used in) operating activities |
(35.359) |
49.545 |
35.050 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry Debtors / Income * 365 Days) |
52.51 |
37.02 |
40.33 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry
Debtors) |
6.95 |
9.86 |
9.05 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors
/ Purchases * 365 Days) |
29.77 |
40.67 |
60.15 |
|
|
|
|
|
|
Inventory Turnover (Operating Income
/ Inventories) |
0.57 |
0.64 |
0.59 |
|
|
|
|
|
|
Asset Turnover (Operating Income
/ Net Fixed Assets) |
0.46 |
0.37 |
0.45 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing + Current Liabilities) / Total
Assets) |
0.41 |
0.41 |
0.49 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability
/ Networth) |
0.39 |
0.27 |
0.43 |
|
|
|
|
|
|
Current Liabilities to Networth (Current
Liabilities / Net Worth) |
0.69 |
0.69 |
0.87 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets
/ Networth) |
0.57 |
0.71 |
0.80 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial
Charges) |
6.82 |
3.59 |
5.30 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) *
100) |
% |
2.44 |
1.18 |
2.80 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total
Assets) * 100) |
% |
5.16 |
2.83 |
5.56 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth)
* 100) |
% |
8.76 |
4.79 |
11.04 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current Assets / Current Liabilities) |
1.59 |
1.41 |
1.34 |
|
|
|
|
|
|
Quick Ratio ((Current Assets
– Inventories) / Current Liabilities) |
0.93 |
0.82 |
0.64 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total
Assets) |
0.59 |
0.59 |
0.50 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity
Capital) |
4.00 |
2.55 |
3.92 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current
Assets / Total Current Liabilities) |
1.59 |
1.41 |
1.34 |
Total Liability = Short-term Debt + Long-term
Debt + Current Maturities of Long-term debts
FINANCIAL ANALYSIS
[all figures are
INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Share Capital |
25.368 |
25.368 |
25.368 |
|
Reserves & Surplus |
205.969 |
215.216 |
238.308 |
|
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
231.337 |
240.584 |
263.676 |
|
|
|
|
|
|
Long Term borrowings |
25.372 |
0.000 |
0.000 |
|
Short Term borrowings |
74.084 |
64.733 |
101.547 |
|
Total
borrowings |
99.456 |
64.733 |
101.547 |
|
Debt/Equity
ratio |
0.430 |
0.269 |
0.385 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales
|
912.760 |
974.972 |
948.282 |
|
|
|
6.816 |
(2.738) |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales
|
912.760 |
974.972 |
948.282 |
|
Profit |
25.550 |
11.532 |
23.092 |
|
|
2.80% |
1.18% |
2.44% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
No |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
No |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
OPERATIONS:
The Company continues to be engaged in the activities pertaining to manufacturing and marketing a wide range of pharmaceutical formulations with special focus in the areas of Dental and Oral care products. The Company has carved out a niche in the dental segment with new innovative products, for the first time in the country.
The Company has three business verticals, Manufacturing and Marketing operations for its own brands, Contract Development and Manufacturing and Distribution of Dental consumables
PERFORMANCE FOR THE
YEAR:
Even though the current year's profits before tax has shown an increase of INR 16.027 Million, the sales turnover has declined compared to the previous year due to various factors affecting the industry in general and the Company in particular. This marginal increase in the current year is due to extra-ordinary payments made in the previous year, which reduced the previous year's operating results. The pressures due to the banning of Fixed Dose Combination products and the reduction in Prices of some of their key products like Sudin tablets and Sudin kid cough syrup had a negative impact on the profitability. The company had to make revisions in the formulations and also cut prices of some key brands like Sudin Tablets and Sudin Kid syrup. The focus on the dental portfolio helped to mitigate the problems and the company will therefore continue to focus on areas that have the least risks going forward.
OUTLOOK FOR THE
CURRENT YEAR:
The First Quarter of the current Financial Year have been very challenging, with the fall in sales due to the uncertainties emanating out of the implementation of Goods and Service Tax ('GST') from 1st April, 2017. There was a steep reduction in purchases at the retail and wholesale markets in the months of May and June, and also our contract manufacturing partners reduced their off take. This resulted in a steep fall in sales.
The Company has taken all the required measures to overcome these challenges with increased focus on areas of least risk.
The Company has put some new products to improve the sales , notably a dental product by name 'Elsenz' , which has been well accepted and the Company hopes to see a good support for Elsenz in the coming months.
UNSECURED LOAN
|
Unsecured Loan |
31.03.2017 (INR
in Million) |
31.03.2016 (INR
in Million) |
|
Short-term
borrowings |
|
|
|
Loans and advances from directors |
18.100 |
20.600 |
|
|
|
|
|
Total |
18.100 |
20.600 |
INDEX OF CHARGES:
|
SNo |
SRN |
Charge Id |
Charge Holder Name |
Date of Creation |
Date of
Modification |
Date of
Satisfaction |
Amount |
Address |
|
1 |
G50979103 |
90145693 |
CENTRAL BANK OF INDIA |
04/03/2005 |
05/07/2017 |
- |
162500000.0 |
CORPORATE FINANCE BRANCHIST FLOOR ,M.M.O. BUILDING,M.G.ROAD,FORTMUMBAIMH400023IN |
|
2 |
Y10243593 |
90143823 |
CENTRAL BANK OF INDIA |
27/03/2002 |
- |
- |
55000000.0 |
CORPORATE FINANCE BRANCHM.G. ROAD; FORTBOMBAYMH400023IN |
|
3 |
Y10241869 |
90142099 |
CENTRAL BANK OF INDIA |
23/02/1998 |
04/08/2001 |
- |
35000000.0 |
DOCUMENTATION CELL; BOMBAY MAIN OFFICEM.G ROADBOMBAYMH400023IN |
|
4 |
Y10241635 |
90141865 |
CENTRAL BANK OF INDIA |
22/08/1995 |
04/08/2001 |
- |
5000000.0 |
DOCUMENTATION CELL; MUMBAI MAIN OFFICE1ST FLOOR; M.G ROAD; FORTBOMBAYMH400023IN |
|
5 |
Y10241591 |
90141821 |
CENTRAL BANK OF INDIA |
19/11/1994 |
12/07/1999 |
- |
1700000.0 |
BOMBAY MAIN OFFICEM.G ROADBOMBAYMH400023IN |
|
6 |
Y10240354 |
90140584 |
CENTRAL BANK OF INDIA |
31/12/1992 |
15/09/1995 |
- |
21355000.0 |
DOCUMENTATION CELL. MUMBAI MAIN OFFICEM.G. ROAD; FORTBOMBAYMH400023IN |
|
7 |
Y10240347 |
90140577 |
CENTRAL BANK OF INDIA |
10/05/1990 |
- |
- |
21355000.0 |
DOCUMENTATION CELL; MUMBAI MAIN OFFICE1ST FLOOR; M.G ROAD; FORTBOMBAYMH400023IN |
|
8 |
Y10241453 |
90141683 |
CENTRAL BANK OF INDIA |
10/05/1990 |
02/11/1996 |
- |
12555000.0 |
DOCUMENTATION CELL; MUMBAI MAIN OFFICE1ST FLOOR; M.G ROAD; FORTBOMBAYMH400023IN |
|
9 |
Y10241360 |
90141590 |
CENTRAL BANK OF INDIA |
19/11/1984 |
04/08/2001 |
- |
1700000.0 |
DOCUMENTATION CELL; MUMBAI MAIN OFFICE1ST FLOOR; M.G ROAD; FORTBOMBAYMH400023IN |
|
10 |
A01668755 |
90141698 |
CENTRAL BANK OF INDIA |
22/01/1991 |
- |
26/06/2006 |
0.0 |
DOCUMENTATION CELL; MUMBAI MAIN OFFICE1ST FLOOR; M.G ROAD; FORTBOMBAYMH400023IN |
FIXED ASSETS
- Land
- Buildings
- Plant and equipment
- Furniture and fixtures
- Vehicles
- Motor vehicles
- Office equipment
- Computer equipments
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with Government
:
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 64.85 |
|
|
1 |
INR 90.58 |
|
Euro |
1 |
INR 79.96 |
INFORMATION DETAILS
|
Information
Gathered by : |
SPR |
|
|
|
|
Analysis Done by
: |
NSR |
|
|
|
|
Report Prepared
by : |
SUJ |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.